• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Oncolytic adenovirus-mediated MDA-7/IL-24 overexpression enhances antitumor activity in hepatocellular carcinoma cell lines

    2010-07-07 00:59:38ChaoWenXiaoXinBoXueHuiZhangWeiGaoYuanYuKunChenJianWeiZhengandCongJunWang

    Chao-Wen Xiao, Xin-Bo Xue, Hui Zhang, Wei Gao, Yuan Yu, Kun Chen, Jian-Wei Zheng and Cong-Jun Wang

    Shanghai, China

    Oncolytic adenovirus-mediated MDA-7/IL-24 overexpression enhances antitumor activity in hepatocellular carcinoma cell lines

    Chao-Wen Xiao, Xin-Bo Xue, Hui Zhang, Wei Gao, Yuan Yu, Kun Chen, Jian-Wei Zheng and Cong-Jun Wang

    Shanghai, China

    BACKGROUND:Melanoma differentiation-associated gene-7 (MDA-7)/interleukin-24 (IL-24) is a novel tumor suppressor gene, which has suppressor activity in a broad spectrum of human cancer cells. We investigated the effect of the replication-competent oncolytic adenovirus SG600-IL24 and replication-incompetent adenovirus Ad.IL-24, both expressing human MDA-7/IL-24 on the hepatocellular carcinoma cell lines HepG2, Hep3B, SMMC-7721, HCCLM3, and the normal liver cell line L02.

    METHODS:Hepatocellular carcinoma cell lines and the normal liver cell line were infected with SG600-IL24 and Ad.IL-24. The mRNA and protein expression of MDA-7/IL-24 in infected cells was confirmed by RT-PCR, ELISA, and Western blotting. MTT assay was used to investigate the proliferation effect. Hoechst staining and Annexin-V and PI staining were performed to study the MDA-7/IL-24 gene expressed in HCC cell lines and the normal liver cell line. Flow cytometry was used to analyse the cell cycle.

    RESULTS:RT-PCR, ELISA and Western blotting confirmed that the exogenous MDA-7/IL-24 gene was highly expressed in cells infected with SG600-IL24. MTT and apoptosis detection indicated that SG600-IL24 induced growth suppression, promoted apoptosis, and blocked cancer cell lines in the G2/M phase in hepatocellular carcinoma cell lines but not in the normal liver cell line.

    CONCLUSIONS:SG600-IL24 selectively induces growth suppression and apoptosis in hepatocellular carcinomacell linesin vitrobut not in the normal liver cell line L02. Compared with Ad.IL-24, SG600-IL24 dramatically enhances antitumor activity in hepatocellular carcinoma cell lines.

    (Hepatobiliary Pancreat Dis Int 2010; 9: 615-621)

    melanoma differentiation-associated gene-7; interleukin-24; oncolytic adenovirus; hepatocellular carcinoma; gene therapy

    Introduction

    Melanoma differentiation-associated gene-7 (MDA-7), renamed interleukin-24 (IL-24), was identified by Fisher in 1995 through combination of recombinant fibroblast interferon-β and protein kinase C activator mezerein subtraction hybridization.[1]MDA-7/IL-24 can induce growth inhibition and apoptosis in melanoma and other types of cancer cell.[2-5]It was hailed as a novel and interesting development in experimental tumor therapy in the early 21st century.[6]Our previous studies show that Ad.IL-24 selectively destroys a variety of liver cancer cells without any toxic effects and growth inhibition of the normal liver cell line L02. Ad.IL-24 facilitates the release of CytC and Smac from the mitochondria to the cytoplasm, independent of the Fas pathway.[7]MDA-7/IL-24 also inhibits the growth and metastasis of high-transfer (HCCM6) liver xenograft tumors, with synergistic effect when combined with doxorubicin. However, the replication-defective adenovirus has poor targeting, low transfection efficiency, low gene expression effect, and severe immune reaction, therefore limiting its further application to cancer gene therapy. The oncolytic adenovirus, a non-defective virus, has been found to be capable of higher transfection efficiency because the exogenous gene can selectively replicate in tumor cellsand lyse them, with almost no effect on normal cells.[8]Therefore, we used this strategy to construct replicationcompetent oncolytic adenovirus SG600-IL24 which carries human MDA-7/IL-24. Four kinds of liver cancer cell lines and the normal liver cell line were infected to assess gene expression, cell growth inhibition, and cytotoxicity in different cells.

    Methods

    Cell lines and culture conditions

    The HCC cell lines HepG2, Hep3B, SMMC-7721, and HCCLM3 and the normal human liver cell line L02 were from the Institute of Liver Cancer of Fudan University. The cell lines were cultured in high glucose DMEM (HyClone, USA) supplemented with 10% FBS (Gibco, USA). SMMC-7721 and L02 were cultured in RPMI-1640 (HyClone, USA) supplemented with 10% FBS. All cell lines were cultured at 37 ℃ in a 5% CO2 humidified incubator.

    Virus construction and production

    Ad.IL-24 was constructed as in our previous work.[9]The oncolytic adenoviruses SG600-IL24 and SG600-EGFP were constructed and amplified as previously described. The IL-24 expression cassette was released from pZD55-IL-24 and introduced into pClon9-INS to produce pClon9-INS-IL24. Using a plasmid transfection method, we co-transfected the pSG600-IL24 and adenovirus skeletal plasmid pPE3 into HEK293 cells to construct the recombinant adenovirus vector SG600-IL24, which carried the mda-7 gene, by intracellular homologous recombination. The genomes were analyzed to confirm the recombinant structure and then the virus was plaque purified and amplified in HEK293 cells. The virus titers were determined by TCID50 assay in HEK293 cells. The titer of SG600-IL24 was 2.25× 1010PFU/ml, SG600-EGFP was 2.79×1010PFU/ml, and Ad.IL-24 was 7.1×109PFU/ml; they were stored at -80 ℃.

    Reagents

    RT-PCR kit (Takara, Japan), enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Minneapolis, MN, USA), MTT (Sigma, St. Louis, MO, USA), Hoechst33258 reagent (Sigma), Annexin-V/PI kit (Sigma), and anti-MDA-7/IL-24 (Abcam, UK).

    Virus infection

    Six-well plates for each cell line were divided into 4 groups: control, Ad.IL-24, SG600-EGFP and SG600-IL24; the control group was treated with serum-free DMEM. The oncolytic adenovirus infected the cells at a MOI (multiplicity of infection, MOI) of 10.

    Expression of MDA-7/IL-24 determined by RT-PCR

    Cells were harvested 24 hours after SG600-IL24 infection to determine mRNA expression of MDA-7/ IL-24. Total RNA was extracted and RT-PCR was performed as previously described. The sequences of primers of MDA-7 mRNA were: sense, 5'-GGG CTG TGA AAG ACA CTA T-3', antisense, 5'-GCA TCC AGG TCA GAA GAA-3'. The length of amplified fragment was 381bp. The sequences of primers of β-actin were: sense, 5'-CCT TCC TGG GCA ATG GAG TCC T-3', and antisense, 5'-GGA ACA ATG ATC TTG ATC TT-3'. The length of amplified fragment was 201bp. Reaction mixtures with corresponding primers were amplified under the following conditions: denaturation at 94 ℃ 5 minutes; denaturation at 94 ℃ 30 seconds, annealing at 56 ℃ 30 seconds, and extension at 72 ℃ 45 seconds for 30 cycles; then extension at 72 ℃ 10 minutes to ensure full extension of the product. The amplified products were visualized by electrophoresis on a 1% agarose gel.

    Detection of IL-24 by ELISA

    Two-antibody sandwich ELISA was developed for detection of human MDA-7/IL-24. The antibodies used were monoclonal mouse anti-human IL-24 (R&D Systems), and peroxidaseconjugated rabbit anti-goat IgG (R&D Systems). The cell culture supernatant was collected at 24 hours, 48 hours and 72 hours and stored at -20 ℃. The concentrations of MDA-7/IL-24 in the supernatant at different times were evaluated by ELISA. The absorbance was read at 450 nm. The concentration of IL-24 was evaluated with a standard curve.

    MTT assay to determine cell growth

    The cells were seeded into 96-well tissue culture plates (1×103cells per well), and treated with PBS, 10 MOI of Ad.IL-24, SG600-EGFP, or SG600-IL24 the next day. After cultivation for 24 hours, the medium was removed, and fresh medium containing 0.5 mg/ml MTT was added to each well. The cells were incubated at 37 ℃for 4 hours, and then the supernatant was removed, and about 150 μl dimethylsulfoxide was added to each well and cells incubated for another 10 minutes at 37 ℃with gentle shaking. Absorbance was read on a Bio-Rad microplate reader at 595 nm.

    Western blotting analysis

    Cell lines were cultured in 6-well plates, and cells receiving different treatments were collected at theindicated times. Forty-eight hours later the cells were collected and suspended in lysis BCA method for protein quantitation. A total of 25 μg of proteins was applied to 15% SDS-PAGE and transferred to polyvinylidene fluoride membranes. The membranes were probed with polyclonal antibodies to MDA-7/IL-24 and β-actin, then the corresponding fluorescent secondary antibody hybridization, and finally the second antipolyvinylidene fluoride membrane fluorescence signal was detected with infrared imaging systems.

    Hoechst33258 staining

    Forty-eight hours after infection, cells were washed twice with PBS and fixed in 1 ml of 4% paraformaldehyde for 10 minutes at 4 ℃. After two washes with PBS, each well was stained with 100 μl Hoechst33258 in PBS for 15 minutes in the dark at room temperature, and then 1000 cells were counted under a fluorescence microscope. Nuclear fragmentation was visualized using a fluorescence microscope (TE2000-U, Nikon, JPN). Apoptotic cells were identified by condensation and fragmentation of nuclear chromatin.

    Fluorescence-activated cell sorter (FACS) analysis

    Cells were harvested 48 hours after administration, trypsinized and washed twice with complete media 48 hours later. Aliquots of cells (1×106) were resuspended in 500 μl binding buffer and stained with 5 μl fluorescein isothiocyanate (FITC)-labeled annexin-V according to the manufacturer's instructions. Propidium iodide (PI, 5 μl) was added to the samples after staining with annexin-V, and then put in the dark for 30 minutes. Flow cytometry (BD, FACSCalibur, USA) was performed immediately after staining.

    Cell-cycle analysis

    Cells were cultured as previously, and after reaching 30% confluence they were treated with DMEM without fetal bovine serum (FBS) for 24 hours for synchronization. The cells were divided into 4 groups: DMEM, Ad.IL-24, SG600-EGFP, and SG600-IL24. Forthy-eight hours later, the cells were harvested using trypsin and the cell concentration adjusted to l×106/ml. After the cells were fixed in 70% cold ethanol overnight at -20 ℃, they were washed with phosphate buffered saline (PBS), and aliquots of 1×106cells were resuspended in 1 ml PBS containing 1 mg/ml of RNase A and 0.5 mg/ml PI. After 30 minutes of incubation, the cells were analyzed by flow cytometry using a FACScan flow cytometer (BD, FACSCalibur, USA). The treated cells were evaluated by FACS analysis for identifying the cells at different stages of the cell cycle. The percentages of G0/G1, S, and G2/M stage cells were determined using multicycle software and the results analyzed using analysis of variance.

    Statistical analysis

    All analyses were performed with SPSS14.0 software. All the experiments were performed at least for three times. Results are expressed as mean±SD. Statistical comparisons were made using analysis of variance. APvalue less than 0.05 was considered statistically significant.

    Results

    SG600-IL24 mediated ectopic MDA-7/IL-24 expression in cells

    The expression of MDA-7/IL-24 mRNA was markedly upregulated in the normal liver cell line (L02) as well as in the different metastatic potential HCC cell lines (HepG2, Hep3B, SMMC-7721, and HCCLM3) that were infected with SG600-IL24. In contrast, cells infected with Ad.IL-24, SG600-EGFP, and DMEM expressed very low levels of MDA-7/IL-24 (Fig. 1).

    Detection of MDA-7/IL-24 in supernatants by ELISA

    Fig. 1. Expression of MDA-7/IL-24 mRNA in a variety of HCC cell lines and normal liver cell line. A: Lanes 1-4, Ad.IL-24, SG600-EGFP, control, and SG600-IL24 groups, respectively. B: corresponding β-actin.

    Fig. 2. Protein expression of MDA-7/IL-24 after SG600-IL24 transfection into HCC cell lines and normal liver cell line. Lanes 1 and 6, control; lane 2, Ad.IL-24 group; lane 7, SG600-EGFP group; lanes 3-5, HepG2, Hep3B, and SMMC-7721 SG600-IL24 groups, respectively; lanes 8 and 9, HCCLM3 and L02 SG600-IL24 groups, respectively.

    Fig. 3. Cell viability of different HCC cell lines and normal liver cell line infected with the oncolytic adenovirus SG600-IL24 and replication-incompetent adenovirus Ad.IL-24 measured by MTT assay at 24, 48, 72 and 96 hours postinfection. Results are presented as mean±SD (n=5) and are expressed as a percentage relative to the DMEM-treated control cells. Data are presented as mean±SD of three independent experiments.

    Table 1. Protein concentrations of MDA-7/IL-24 in different HCC cell lines and normal cell line (pg/ml)

    Table 2. Analysis of apoptosis by Hoechst staining

    In SG600-IL24-treated cells, the concentrations of MDA-7/IL-24 protein in supernatants increased in a time-dependent manner. Endogenous MDA-7/IL-24 expression was not detected in cells treated with SG600-EGFP and control groups (Table 1).

    Protein expression of MDA-7/IL-24 by Western blotting

    Five cells in the control, Ad.IL-24 and SG600-EGFP groups had no MDA-7/IL-24 protein expression, but transfection of the oncolytic adenovirus SG600-IL24 showed very high expression of MDA-7/IL-24 48 hours later (Fig. 2).

    Growth suppression and viability assays

    To investigate whether SG600-IL24 inhibits cell proliferation, HCC cells HepG2, Hep3B, SMMC-7721, HCCLM3 and the normal liver cell line L02 were infected with SG600-IL24, and proliferation and cell viability were determined by MTT. There was no proliferation arrest effect in normal liver cell line L02, regardless of treatment with DMEM, Ad.IL-24 or SG600-EGFP. However, the anti-proliferative activity of SG600-IL24 was readily apparent in HCC cell lines HepG2, Hep3B, SMMC-7721, and HCCLM3; the inhibition ratios were 75±2.5%, 85±2.0%, 86±3.5%, and 72±1.8%, respectively (Fig. 3).

    SG600-IL24 induced apoptosis in HCC cell lines as assessed by Hoechst staining

    Hoechst staining showed that SG600-IL24 induced apoptosis in human HCC cells lines HepG2, Hep3B, SMMC-7721, and HCCLM3 (Table 2). SG600-IL24-mediated apoptosis in HCC cell lines was higher than in the other groups (HepG2:F=156.6,P<0.05; Hep3B:F=202.4,P<0.05; SMMC-7721:F=122.5,P<0.05;HCCLM3:F=138.0,P<0.05). These data indicated that SG600-IL24 induced apoptosis in HCC cell lines. In contrast, there were no apparent changes in the normal liver cell line L02, where the rates of apoptosis were 1.0%, 1.4%, 1.2% and 2.0%, respectively (F=1.78,P>0.05).

    Table 3. Analysis of apoptosis in HCC cell lines by flow cytometry

    Fig. 4. SG600-IL24 induces G2/M arrest in HCC cell lines.

    Apoptosis affected assay by flow cytometry

    Annexin-V and PI staining assays with flow cytometry quantified the effect of SG600-IL24 on apoptosis induction in the HCC cell lines HepG2, Hep3B, SMMC-7721, HCCLM3 and the normal liver cell line L02. The percentage of apoptosis in HCC cell lines increased significantly in the SG600-IL24-infected compared to the control, SG600-EGFP, and Ad.IL-24 infected cells (HepG2:F=203.4,P<0.05; Hep3B:F=313.2,P<0.05; SMMC-7721:F=130.5,P<0.05; HCCLM3:F=142.3,P<0.05) (Table 3). When compared L02 with HCC cell lines, the apoptosis rate was only increased by 0.75%, demonstrating that SG600-IL24 infection can kill HCC cell lines but not normal liver cell line.

    Cell cycle analysis by flow cytometry

    Cell cycle phases assayed with flow cytometry showed that SG600-IL24 induced a G2/M accumulation in HepG2, Hep3B, SMMC-7721, and HCCLM3 carcinoma cell lines compared with the control, Ad.IL-24 and SG600-EGFP groups (P<0.05; Fig. 4). The rates of G2/M phase were 35.4±4.2%, 47.3±6.2%, 40.5± 5.0%, and 45.5±4.0% respectively. However, the rates of G2/M phase in the L02 cell line were 5.5±0.3%, 5.6± 0.2%, 6.3±0.4%, and 6.8±0.7%, respectively (P>0.05). These results showed that SG600-IL24 infection induced an increase in the G2/M proportion of the cell cycle in HCC cell lines but not in normal liver cell lines.

    Discussion

    Hepatocellular carcinoma (HCC) is one of the highest malignant tumors. The annual morbidity and mortality associated with HCC are the second highest among tumors.[10]In addition, HCC is characterized by poor prognosis. To address this, cancer gene therapy has been on the rise. Recently, sorafenib has been approved for clinical application.[11]However, its actual effects are still being examined. Genes or drugs that can treat tumor cells whetherin vivoor specific to metastatic tumor cells, without any toxic effects to normal cells, are essential to the treatment of liver cancer and other tumors.

    MDA-7/IL-24, IL-24, is a new member of the IL-10, class-II family of cytokines. Studies have found that MDA-7/IL-24 not only induces growth inhibition of melanoma cells but also facilitates growth suppression and apoptosis in a broad range of carcinoma cell lines, such as those of ovarian cancer,[12,13]and carcinomas of the lungs,[14,15]breast,[16]pancreas,[17]glioma,[17,18]prostate[19]and colon[20]among others. Studies have likewise indicated that increased expression of the IL-24 gene suppresses growth and induces apoptosis in a variety of cancer cells with single or multiple genetic defects, including alterations in p53, p16/INK4a, and Rb.[21,22]

    Gene therapy for liver cancer is a current research focus; most of the reported methods are not tumorspecific but affect normal cells, which limits their clinical application. Gene therapy that is capable of selectively curing tumor cells without affecting normal cells can be explored.[23]In this study, an oncolytic adenovirus, with the characteristics of antitumor activity and proliferation and replication in tumor cells specifically, was used as a carrier. These oncolytic adenoviruses can make the exogenous gene copy thousands of times and enhance the effect of the anticancer gene in a similar manner, ultimately killing tumor cells for therapeutic purposes.[24]Tumor-specific oncolytic adenovirus vectors have the capability to cure specific infections of tumor cells, amplify in a large number of infected cells, and dissolve tumor cells. Therefore they are promising gene therapy vectors with anti-tumor effects.[25]In this study we constructed adenovirus SG600-IL24, which has E1B 55 kDa defective oncolytic adenovirus (ZD55). It replicates in tumor cells and causes a significant cytotoxic effect, whilenormal cells show little or no toxicity.[26]SG600-IL24 was constructed by oncolytic adenovirus SG600 vector which has the telomerase reverse transcriptase promoter (TERTp), and hypoxia regulatory element (HRE) controls the adenovirus proliferation genes E1a and E1b. It deletes the E1a gene, which promotes virus-specific replication in tumor cells, therefore it has enhanced effectiveness and safety for gene therapy.[27]

    In contrast to the replication-incompetent adenovirus Ad.IL-24, the oncolytic adenovirus can replicate in and lyse tumor cells exclusively, inducing a high expression of MDA-7/IL-24 in these cells. This high expression of MDA-7/IL-24 can selectively kill cancer cells simultaneously. Moreover, when the oncolytic adenovirus selectively kills tumor cells, MDA-7/IL-24 can be released to the blood, indicating a potent "bystander" antitumor activity.[28]It can also kill distant micrometastatic lesions resulting from radical treatment.

    SG600-IL24 was utilized as a vector. RT-PCR, ELISA, and Western blotting demonstrated that MDA-7/IL-24 was successfully transfected into the HCC cell lines and normal liver cell line. The control group and the SG600-EGFP group did not express the MDA-7/IL-24 gene and protein. Although the SG600-IL24 group comprising five kinds of cell lines expressed the MDA-7/ IL-24 protein, the effects were different. ELISA results showed that the expression of secreted and intracellular MDA-7/IL-24 proteins increased in a time-dependent manner in the SG600-IL24 group. This indicates that the enhanced killing was due to increased MDA-7/ IL-24 protein expression. At the same time, the rate of apoptosis increased with time. These findings suggest that there is a positive correlation between time and the protein concentration after SG600-IL24 was infected into the HCC cell lines. Flow cytometry results showed that SG600-IL24 significantly inhibited the growth of tumor cells, promoted the apoptosis of tumor cells, and blocked tumor cells in the G2/M phase. Normal L02 liver cells were not affected although an increase in G2/M phase by 1.3% was observed. Annexin-V and PI staining by flow cytometry showed that the early and late apoptosis rates in HepG2, Hep3B, SMMC-7721, and HCCLM3 were 56.59%, 78.36%, 34.46%, and 40.03%. The apoptosis rate was only 0.75% in the normal liver cell line L02. These results demonstrated that SG600-IL24 did not promote apoptosis in the normal liver cell line. MTT and Hoechst33258 staining results suggested that SG600-IL24 promoted apoptosis and induced the killing effect in a variety of different HCC cell lines with metastatic potential but not in the normal liver cell line L02. These effects showed stronger antitumor activity than the replication-incompetent adenovirus Ad.IL-24, which showed little or low killing capacity under the same conditions.

    The HCC cell line HepG2 is a wild type in the gene p53 and a mutant type in the gene Rb. Hep3B is a line with the p53 gene deleted. HCCLM3 is a mutant type in the gene p53.[29-32]Although these lines have different gene types, they induce apoptosis and growth arrest by infection with SG600-IL24. The results demonstrated that SG600-IL24 killed several kinds of tumor cells independent of the state of p53. Hep3B is a line without metastatic potential. In comparison, HCCLM3 and SMMC-7721 are lines with high metastatic potential. Research has shown that HCCLM3 is a strong metastatic line which can develop liver cancer metastasis in 100% of nude mice.[29-32]Therefore, SG600-IL24 can facilitate HCC cell lines with different metastatic potential.

    In conclusion, SG600-IL24 can induce growth suppression, promote apoptosis, and block cancer cell lines in the G2/M phase in HCC cell lines without any toxic effect on normal liver cell line lines. In contrast with Ad.IL-24, SG600-IL24 enhances antitumor activity in HCC cell lines dramatically. These findings provide support for future clinical applications of MDA-7/IL-24 in the gene therapy of HCC. Therefore, the strategy called targeted gene-virotherapy is an efficient approach in anticancer therapies.

    Acknowledgements

    We thank Virginia Commonwealth University Professor Paul B. Fisher for his instruction and encouragement. We are also grateful to Qi-Jun Qian of Shanghai Eastern Hepatobiliary Surgery Hospital for his guidance on virus construction and laboratory techniques.

    Funding:This work was supported by a grant from the National Natural Science Foundation of China (30872510).

    Ethical approval:Not needed.

    Contributors:WCJ and ZH proposed the study. XCW wrote the first draft. CK analyzed the data. All authors contributed to the design and interpretation of the study and to further drafts. WCJ is the guarantor.

    Competing interest:No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    1 Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004;22:929-979.

    2 Yacoub A, Hamed HA, Allegood J, Mitchell C, Spiegel S, Lesniak MS, et al. PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells. Cancer Res 2010;70:1120-1129.

    3 Park MA, Walker T, Martin AP, Allegood J, Vozhilla N, Emdad L, et al. MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism. Mol Cancer Ther 2009;8:1280-1291.

    4 Hamed HA, Yacoub A, Park MA, Eulitt P, Sarkar D, Dimitriev IP, et al. OSU-03012 enhances Ad.mda-7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins. Cancer Biol Ther 2010;9.

    5 Maarof G, Bouchet-Delbos L, Gary-Gouy H, Durand-Gasselin I, Krzysiek R, Dalloul A. Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells. Blood 2010;115:1718-1726.

    6 Los M. New, exciting developments in experimental therapies in the early 21st century. Eur J Pharmacol 2009;625:1-5.

    7 Wang C, Xue X, Yi J, Wu Z, Chen K, Zheng J, et al. Replicationincompetent adenovirus vector-mediated MDA-7/IL-24 selectively induces growth suppression and apoptosis of hepatoma cell Line SMMC-7721. J Huazhong Univ Sci Technolog Med Sci 2008;28:80-83.

    8 Wei N, Fan JK, Gu JF, Liu XY. Double-regulated oncolytic adenovirus-mediated interleukin-24 overexpression exhibits potent antitumor activity on gastric adenocarcinoma. Hum Gene Ther 2010;21:855-864.

    9 Wang CJ, Xue XB, Yi JL, Chen K, Zheng JW, Wang J, et al. Melanoma differentiation-associated gene-7, MDA-7/IL-24, selectively induces growth suppression, apoptosis in human hepatocellular carcinoma cell line HepG2 by replicationincompetent adenovirus vector. World J Gastroenterol 2006; 12:1774-1779.

    10 Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.

    11 Furuse J. Growth factors as therapeutic targets in HCC. Crit Rev Oncol Hematol 2008;67:8-15.

    12 Mahasreshti PJ, Kataram M, Wu H, Yalavarthy LP, Carey D, Fisher PB, et al. Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy. Gynecol Oncol 2006;100:521-532.

    13 Gopalan B, Litvak A, Sharma S, Mhashilkar AM, Chada S, Ramesh R. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Cancer Res 2005;65:3017-3024.

    14 Kawabe S, Nishikawa T, Munshi A, Roth JA, Chada S, Meyn RE. Adenovirus-mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms. Mol Ther 2002;6:637-644.

    15 Ramesh R, Ito I, Gopalan B, Saito Y, Mhashilkar AM, Chada S. Ectopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cells. Mol Ther 2004;9:510-518.

    16 McKenzie T, Liu Y, Fanale M, Swisher SG, Chada S, Hunt KK. Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells. Surgery 2004;136:437-442.

    17 Lebedeva IV, Su ZZ, Sarkar D, Gopalkrishnan RV, Waxman S, Yacoub A, et al. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis. Oncogene 2005; 24:585-596.

    18 Yacoub A, Mitchell C, Hong Y, Gopalkrishnan RV, Su ZZ, Gupta P, et al. MDA-7 regulates cell growth and radiosensitivityin vitroof primary (non-established) human glioma cells. Cancer Biol Ther 2004;3:739-751.

    19 Lebedeva IV, Su ZZ, Sarkar D, Kitada S, Dent P, Waxman S, et al. Melanoma differentiation associated gene-7, mda-7/ interleukin-24, induces apoptosis in prostate cancer cells by promoting mitochondrial dysfunction and inducing reactive oxygen species. Cancer Res 2003;63:8138-8144.

    20 Zhao L, Gu J, Dong A, Zhang Y, Zhong L, He L, et al. Potent antitumor activity of oncolytic adenovirus expressing mda-7/ IL-24 for colorectal cancer. Hum Gene Ther 2005;16:845-858.

    21 Lebedeva IV, Su ZZ, Chang Y, Kitada S, Reed JC, Fisher PB. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene 2002;21:708-718.

    22 Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, et al. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 2001;20:7051-7063.

    23 Su ZZ, Lebedeva IV, Sarkar D, Gopalkrishnan RV, Sauane M, Sigmon C, et al. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene 2003;22:1164-1180.

    24 Zhang ZL, Zou WG, Luo CX, Li BH, Wang JH, Sun LY, et al. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy. Cell Res 2003;13:481-489.

    25 Crompton AM, Kirn DH. From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development. Curr Cancer Drug Targets 2007;7:133-139.

    26 Liu XY, Gu JF. Targeting gene-virotherapy of cancer. Cell Res 2006;16:740.

    27 Luo J, Xia Q, Zhang R, Lv C, Zhang W, Wang Y, et al. Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene. Clin Cancer Res 2008;14:2450-2457.

    28 Sarkar D, Su ZZ, Park ES, Vozhilla N, Dent P, Curiel DT, et al. A cancer terminator virus eradicates both primary and distant human melanomas. Cancer Gene Ther 2008;15:293-302.

    29 Yang J, Qin LX, Li Y, Ye SL, Liu YK, Gao DM, et al. Molecular cytogenetic characteristics of the human hepatocellular carcinoma cell line HCCLM3 with high metastatic potential: comparative genomic hybridization and multiplex fluorescence in situ hybridization. Cancer Genet Cytogenet 2005;158:180-183.

    30 Tian B, Li Y, Ji XN, Chen J, Xue Q, Ye SL, et al. Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential. J Cancer Res Clin Oncol 2005;131:80-86.

    31 Ding SJ, Li Y, Shao XX, Zhou H, Zeng R, Tang ZY, et al. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 2004;4:982-994.

    32 Wu X, Jia HL, Wang YF, Ren N, Ye QH, Sun HC, et al. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma. Oncogene 2006;25:1832-1840.

    May 24, 2010

    Accepted after revision August 12, 2010

    Author Affiliations: Department of Biliary and Pancreatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China (Xiao CW, Xue XB, Yu Y, Chen K and Zheng JW); Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China (Zhang H, Gao W and Wang CJ)

    Cong-Jun Wang, MD, PhD, Department of General Surgery, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China (Tel: 86-21-38804518ext2704; Email: wcj902@163.com)

    ? 2010, Hepatobiliary Pancreat Dis Int. All rights reserved.

    国产黄色小视频在线观看| 中出人妻视频一区二区| 国国产精品蜜臀av免费| 在线免费观看的www视频| 蜜臀久久99精品久久宅男| 亚洲最大成人中文| 波多野结衣巨乳人妻| 一卡2卡三卡四卡精品乱码亚洲| 久久精品夜色国产| 69人妻影院| 亚洲性夜色夜夜综合| 国国产精品蜜臀av免费| 精品久久久久久久久av| 搡老岳熟女国产| 成人av一区二区三区在线看| 欧美三级亚洲精品| 又黄又爽又免费观看的视频| 人妻丰满熟妇av一区二区三区| 99久国产av精品| 亚洲欧美精品综合久久99| 国产日本99.免费观看| 亚洲国产色片| 国产人妻一区二区三区在| 国产精品嫩草影院av在线观看| 美女内射精品一级片tv| videossex国产| 成人性生交大片免费视频hd| 搡老妇女老女人老熟妇| АⅤ资源中文在线天堂| 一区福利在线观看| 午夜福利18| 搡老岳熟女国产| 国产亚洲91精品色在线| 色综合站精品国产| 亚洲性夜色夜夜综合| 欧美成人a在线观看| 免费观看的影片在线观看| 午夜福利视频1000在线观看| 18禁黄网站禁片免费观看直播| 国产精品综合久久久久久久免费| 夜夜看夜夜爽夜夜摸| 亚洲人成网站在线播放欧美日韩| 精品久久久久久久人妻蜜臀av| 又爽又黄a免费视频| 成年av动漫网址| 亚洲精品456在线播放app| 可以在线观看的亚洲视频| 亚洲四区av| 久久午夜亚洲精品久久| 色播亚洲综合网| 91久久精品国产一区二区成人| 18禁在线无遮挡免费观看视频 | 久久国内精品自在自线图片| 男人和女人高潮做爰伦理| 国产精品一区www在线观看| 在线观看午夜福利视频| 欧美成人一区二区免费高清观看| 禁无遮挡网站| 男人和女人高潮做爰伦理| 久久久色成人| 欧美色视频一区免费| 欧美成人一区二区免费高清观看| 日韩高清综合在线| 国产成人影院久久av| 久久久久九九精品影院| 精品久久久久久久末码| 六月丁香七月| 偷拍熟女少妇极品色| 99九九线精品视频在线观看视频| 国产精品福利在线免费观看| 神马国产精品三级电影在线观看| 日韩成人伦理影院| 18+在线观看网站| 啦啦啦观看免费观看视频高清| 欧美潮喷喷水| 午夜视频国产福利| 久久久久久久久中文| 日韩成人伦理影院| 日日摸夜夜添夜夜添小说| 青春草视频在线免费观看| 亚洲av成人精品一区久久| 色尼玛亚洲综合影院| 国产av一区在线观看免费| 校园春色视频在线观看| 校园春色视频在线观看| 性欧美人与动物交配| 最近2019中文字幕mv第一页| 亚洲欧美中文字幕日韩二区| 性色avwww在线观看| 俄罗斯特黄特色一大片| 欧美性猛交黑人性爽| 久久亚洲精品不卡| 久久精品国产自在天天线| 在线免费观看的www视频| 久久亚洲精品不卡| 国产精品,欧美在线| 国产黄a三级三级三级人| 丰满人妻一区二区三区视频av| 国产精品人妻久久久影院| 亚洲国产欧洲综合997久久,| 国产一区亚洲一区在线观看| 国产精品一区二区三区四区久久| 久久久精品欧美日韩精品| 听说在线观看完整版免费高清| 精品久久久久久久久av| 亚洲国产欧美人成| 欧美一区二区亚洲| 卡戴珊不雅视频在线播放| 毛片一级片免费看久久久久| 在线观看美女被高潮喷水网站| 乱人视频在线观看| 男女之事视频高清在线观看| av视频在线观看入口| 一级毛片我不卡| 精品欧美国产一区二区三| 国产真实乱freesex| 午夜激情欧美在线| 99热这里只有是精品在线观看| 国产91av在线免费观看| 亚洲美女搞黄在线观看 | 免费无遮挡裸体视频| 三级经典国产精品| 人人妻人人澡人人爽人人夜夜 | 久久久久性生活片| 久久99热6这里只有精品| 日本黄色片子视频| 老司机福利观看| 国产91av在线免费观看| 亚洲图色成人| 精品久久久久久久久久久久久| 欧美国产日韩亚洲一区| 国产在视频线在精品| av在线老鸭窝| 直男gayav资源| 在现免费观看毛片| 黄色视频,在线免费观看| 乱人视频在线观看| 免费搜索国产男女视频| 午夜福利视频1000在线观看| 国产欧美日韩一区二区精品| 能在线免费观看的黄片| 夜夜夜夜夜久久久久| 成年免费大片在线观看| 成熟少妇高潮喷水视频| 精品久久久噜噜| 亚洲人成网站在线观看播放| 成人高潮视频无遮挡免费网站| 欧美日韩一区二区视频在线观看视频在线 | 久久久色成人| 1024手机看黄色片| 午夜爱爱视频在线播放| 亚洲四区av| 精品无人区乱码1区二区| 久久99热6这里只有精品| 亚洲第一电影网av| 国产精品电影一区二区三区| 欧美潮喷喷水| 国产精品乱码一区二三区的特点| 蜜臀久久99精品久久宅男| 久久99热这里只有精品18| 中文字幕熟女人妻在线| 岛国在线免费视频观看| 插阴视频在线观看视频| 午夜福利视频1000在线观看| 国产中年淑女户外野战色| 天堂影院成人在线观看| 青春草视频在线免费观看| 麻豆一二三区av精品| 又黄又爽又免费观看的视频| 在线观看av片永久免费下载| 神马国产精品三级电影在线观看| 国产 一区精品| 91麻豆精品激情在线观看国产| 国产av不卡久久| 亚洲五月天丁香| 乱系列少妇在线播放| 又爽又黄无遮挡网站| 日韩一区二区视频免费看| 亚洲人成网站在线播放欧美日韩| 日韩中字成人| 少妇的逼好多水| 91在线精品国自产拍蜜月| 高清毛片免费观看视频网站| 国产麻豆成人av免费视频| 国内久久婷婷六月综合欲色啪| 国产精品野战在线观看| av福利片在线观看| 又粗又爽又猛毛片免费看| 无遮挡黄片免费观看| 久久人人爽人人爽人人片va| 亚洲精品影视一区二区三区av| 久久久国产成人精品二区| 亚洲在线自拍视频| 国语自产精品视频在线第100页| 午夜福利在线在线| 一a级毛片在线观看| 久久精品综合一区二区三区| 久久久色成人| 亚洲在线观看片| 国产伦在线观看视频一区| 久久热精品热| 亚洲最大成人av| 99热这里只有是精品在线观看| 真实男女啪啪啪动态图| 看片在线看免费视频| 伦精品一区二区三区| 国内少妇人妻偷人精品xxx网站| 精品乱码久久久久久99久播| 精品久久久久久久末码| 国产精品一区www在线观看| 亚洲精品乱码久久久v下载方式| 尾随美女入室| 国产三级中文精品| 日韩欧美一区二区三区在线观看| 日本免费a在线| 欧美色欧美亚洲另类二区| 精品一区二区三区av网在线观看| 日韩国内少妇激情av| 国内精品美女久久久久久| 精品久久久久久久久亚洲| 天堂√8在线中文| 夜夜爽天天搞| 成人鲁丝片一二三区免费| 成人综合一区亚洲| 欧美区成人在线视频| 久久精品国产自在天天线| 露出奶头的视频| 久久久色成人| 亚洲人成网站在线播| 国产欧美日韩精品一区二区| 久久久久国产网址| 国产三级中文精品| 国产精品,欧美在线| 欧美激情在线99| 美女高潮的动态| 亚洲欧美日韩高清在线视频| 亚洲国产精品合色在线| 久久欧美精品欧美久久欧美| 免费电影在线观看免费观看| 18禁在线播放成人免费| 99久国产av精品国产电影| 欧美成人免费av一区二区三区| 亚洲丝袜综合中文字幕| 女同久久另类99精品国产91| 欧美日韩乱码在线| 插阴视频在线观看视频| 成年av动漫网址| 看黄色毛片网站| 人妻夜夜爽99麻豆av| 一级a爱片免费观看的视频| 亚洲自偷自拍三级| 日日干狠狠操夜夜爽| 国产真实乱freesex| 精品午夜福利视频在线观看一区| 亚洲在线观看片| 亚洲精品一卡2卡三卡4卡5卡| 亚洲精品一区av在线观看| 免费高清视频大片| 国产高清有码在线观看视频| 日韩 亚洲 欧美在线| 亚洲av电影不卡..在线观看| 国产亚洲精品av在线| 欧美又色又爽又黄视频| 亚洲内射少妇av| 99在线视频只有这里精品首页| 国产精品一区二区免费欧美| av天堂中文字幕网| 国产 一区精品| 嫩草影院精品99| 三级毛片av免费| 丝袜喷水一区| .国产精品久久| 精品久久久久久久久亚洲| 狂野欧美激情性xxxx在线观看| 国产淫片久久久久久久久| av黄色大香蕉| 欧美不卡视频在线免费观看| 亚洲美女视频黄频| 搡老妇女老女人老熟妇| 在线看三级毛片| 人人妻人人看人人澡| 亚洲自拍偷在线| 成人午夜高清在线视频| 亚洲天堂国产精品一区在线| 国产精品一区二区三区四区免费观看 | 久久欧美精品欧美久久欧美| 日韩强制内射视频| 国产精品美女特级片免费视频播放器| 国产伦精品一区二区三区四那| 日本成人三级电影网站| 色在线成人网| 亚洲精品粉嫩美女一区| 国产精品久久久久久av不卡| 久久久久性生活片| 国产激情偷乱视频一区二区| 国产午夜福利久久久久久| 久久婷婷人人爽人人干人人爱| 亚洲七黄色美女视频| 免费在线观看成人毛片| 亚洲av中文字字幕乱码综合| 国产女主播在线喷水免费视频网站 | 国产v大片淫在线免费观看| 国产精品1区2区在线观看.| 国产不卡一卡二| 亚洲国产精品成人综合色| 校园春色视频在线观看| 内射极品少妇av片p| 欧美日韩精品成人综合77777| av卡一久久| 久久久久久久亚洲中文字幕| 成人毛片a级毛片在线播放| 99久久中文字幕三级久久日本| 午夜福利在线观看吧| 天堂影院成人在线观看| .国产精品久久| 午夜影院日韩av| 国产精品精品国产色婷婷| 女的被弄到高潮叫床怎么办| 欧美激情久久久久久爽电影| 国产不卡一卡二| 俺也久久电影网| 99热这里只有是精品50| 九九在线视频观看精品| av免费在线看不卡| 国产成人影院久久av| 成人美女网站在线观看视频| 国产精品久久久久久久电影| 99久久中文字幕三级久久日本| 日本一二三区视频观看| 级片在线观看| h日本视频在线播放| 亚洲美女黄片视频| 色哟哟·www| 午夜免费激情av| 亚洲第一电影网av| 国产黄片美女视频| 日韩中字成人| 18禁在线播放成人免费| 51国产日韩欧美| 99久久精品一区二区三区| 国产极品精品免费视频能看的| 色吧在线观看| 国产成人影院久久av| 精品人妻一区二区三区麻豆 | 熟女电影av网| 精品一区二区免费观看| 插阴视频在线观看视频| 国产探花在线观看一区二区| 欧美又色又爽又黄视频| 日本免费a在线| 亚洲美女搞黄在线观看 | 91久久精品国产一区二区成人| 国产av一区在线观看免费| 国产精品一区二区性色av| 国产精品精品国产色婷婷| 一卡2卡三卡四卡精品乱码亚洲| 国产成人精品久久久久久| 91麻豆精品激情在线观看国产| 久久九九热精品免费| 国产av麻豆久久久久久久| 久久久午夜欧美精品| 中国美女看黄片| 久久久久免费精品人妻一区二区| 久久这里只有精品中国| 久久久久久大精品| 干丝袜人妻中文字幕| 插逼视频在线观看| av在线天堂中文字幕| 亚洲乱码一区二区免费版| 18禁裸乳无遮挡免费网站照片| 免费av观看视频| 国产精品免费一区二区三区在线| 成年免费大片在线观看| 国产午夜福利久久久久久| 亚洲av第一区精品v没综合| 日本一本二区三区精品| av国产免费在线观看| 成人av在线播放网站| 白带黄色成豆腐渣| 成年女人永久免费观看视频| 亚洲久久久久久中文字幕| 国产免费一级a男人的天堂| av视频在线观看入口| 国产激情偷乱视频一区二区| 九色成人免费人妻av| 啦啦啦韩国在线观看视频| 精品久久国产蜜桃| 亚洲精华国产精华液的使用体验 | 毛片女人毛片| 国内少妇人妻偷人精品xxx网站| 国产精品美女特级片免费视频播放器| av天堂在线播放| 国产69精品久久久久777片| 最好的美女福利视频网| 国产v大片淫在线免费观看| 日韩中字成人| 天堂影院成人在线观看| 国产国拍精品亚洲av在线观看| 黄色欧美视频在线观看| 国产一区二区在线av高清观看| 国产在线男女| 日韩成人av中文字幕在线观看 | 一区二区三区免费毛片| 欧美绝顶高潮抽搐喷水| АⅤ资源中文在线天堂| 日本三级黄在线观看| 日韩人妻高清精品专区| 九色成人免费人妻av| 欧美成人免费av一区二区三区| 一个人看的www免费观看视频| 99久久中文字幕三级久久日本| 国产人妻一区二区三区在| 一级黄色大片毛片| 综合色av麻豆| 久久久国产成人精品二区| 国产精品亚洲一级av第二区| 国产精品久久久久久精品电影| 69人妻影院| 非洲黑人性xxxx精品又粗又长| 婷婷精品国产亚洲av| 免费看美女性在线毛片视频| 成人综合一区亚洲| 九九久久精品国产亚洲av麻豆| 欧美丝袜亚洲另类| 免费观看在线日韩| 欧美成人a在线观看| 精品少妇黑人巨大在线播放 | 日韩精品中文字幕看吧| 嫩草影院精品99| 联通29元200g的流量卡| 亚洲av.av天堂| 校园春色视频在线观看| 最好的美女福利视频网| 能在线免费观看的黄片| 成年女人看的毛片在线观看| av卡一久久| 精品不卡国产一区二区三区| 简卡轻食公司| 日韩人妻高清精品专区| 国产欧美日韩一区二区精品| 全区人妻精品视频| 91久久精品国产一区二区成人| 亚洲,欧美,日韩| 亚洲熟妇熟女久久| 国产 一区 欧美 日韩| 欧美bdsm另类| 成年女人毛片免费观看观看9| 久久久久久九九精品二区国产| 色综合色国产| 一级av片app| 国产熟女欧美一区二区| 国产一区二区亚洲精品在线观看| 精品午夜福利视频在线观看一区| 不卡一级毛片| 日本爱情动作片www.在线观看 | 国产精品福利在线免费观看| 插阴视频在线观看视频| 国产亚洲精品综合一区在线观看| 精华霜和精华液先用哪个| 俺也久久电影网| 国产探花极品一区二区| 免费高清视频大片| 免费黄网站久久成人精品| 亚洲精品在线观看二区| 亚洲最大成人手机在线| 日韩精品中文字幕看吧| 免费av毛片视频| 老司机福利观看| 村上凉子中文字幕在线| 久久精品夜色国产| ponron亚洲| 久久久国产成人免费| 免费观看在线日韩| 午夜老司机福利剧场| av在线亚洲专区| 国产男人的电影天堂91| 十八禁国产超污无遮挡网站| 我的女老师完整版在线观看| 亚洲不卡免费看| 日韩人妻高清精品专区| 国产真实乱freesex| 精品不卡国产一区二区三区| 乱系列少妇在线播放| 欧美日韩在线观看h| 国产av一区在线观看免费| 亚洲内射少妇av| 内射极品少妇av片p| 一级毛片我不卡| 又粗又爽又猛毛片免费看| 晚上一个人看的免费电影| 我的女老师完整版在线观看| 日韩在线高清观看一区二区三区| 亚洲五月天丁香| 成人毛片a级毛片在线播放| 久久久国产成人精品二区| 日日撸夜夜添| 亚洲成av人片在线播放无| 成人午夜高清在线视频| 身体一侧抽搐| 最新在线观看一区二区三区| 日韩欧美一区二区三区在线观看| 国产在线男女| 性插视频无遮挡在线免费观看| 国内精品美女久久久久久| 欧美丝袜亚洲另类| 精品一区二区免费观看| 麻豆一二三区av精品| 99国产精品一区二区蜜桃av| 女同久久另类99精品国产91| 亚洲va在线va天堂va国产| 欧美区成人在线视频| 亚洲五月天丁香| 99久久九九国产精品国产免费| 欧美日韩乱码在线| 色综合色国产| 成人性生交大片免费视频hd| 看非洲黑人一级黄片| 99热这里只有是精品50| 一级毛片电影观看 | 舔av片在线| 免费人成在线观看视频色| 免费电影在线观看免费观看| 国产精品久久电影中文字幕| 国内揄拍国产精品人妻在线| 成人亚洲精品av一区二区| 99国产极品粉嫩在线观看| 国产美女午夜福利| 12—13女人毛片做爰片一| 一本一本综合久久| 国内精品美女久久久久久| 国产精品一区www在线观看| 国产高清视频在线播放一区| 熟女人妻精品中文字幕| 人妻夜夜爽99麻豆av| 国内精品宾馆在线| 国内精品美女久久久久久| 给我免费播放毛片高清在线观看| 熟女电影av网| 美女内射精品一级片tv| 国语自产精品视频在线第100页| 色播亚洲综合网| 色综合色国产| 亚洲婷婷狠狠爱综合网| 天天一区二区日本电影三级| 综合色丁香网| 亚洲,欧美,日韩| 听说在线观看完整版免费高清| 午夜视频国产福利| a级毛片免费高清观看在线播放| 少妇的逼水好多| 欧美性感艳星| 日韩国内少妇激情av| 精品久久久久久久末码| 国语自产精品视频在线第100页| 久久韩国三级中文字幕| 变态另类成人亚洲欧美熟女| 午夜精品在线福利| 天天躁夜夜躁狠狠久久av| 久久精品国产亚洲网站| 村上凉子中文字幕在线| 如何舔出高潮| www.色视频.com| 淫妇啪啪啪对白视频| 国产一区二区亚洲精品在线观看| 中文资源天堂在线| 日日摸夜夜添夜夜爱| 国产老妇女一区| 国产人妻一区二区三区在| 无遮挡黄片免费观看| 尤物成人国产欧美一区二区三区| 欧美精品国产亚洲| 国产伦一二天堂av在线观看| 色播亚洲综合网| 麻豆久久精品国产亚洲av| 色视频www国产| 日本 av在线| 免费观看精品视频网站| 欧美日韩乱码在线| 精品不卡国产一区二区三区| 国产成人aa在线观看| 国产 一区精品| 蜜桃久久精品国产亚洲av| av免费在线看不卡| 麻豆一二三区av精品| 日日干狠狠操夜夜爽| 欧美三级亚洲精品| 韩国av在线不卡| 久久亚洲精品不卡| 中文字幕久久专区| 欧美日韩乱码在线| 亚洲人成网站在线播放欧美日韩| 1024手机看黄色片| 国产午夜精品久久久久久一区二区三区 | 男女视频在线观看网站免费| 三级男女做爰猛烈吃奶摸视频| 亚洲国产精品成人久久小说 | 亚洲自偷自拍三级| 日韩一区二区视频免费看| 一个人免费在线观看电影| 成人特级黄色片久久久久久久| 韩国av在线不卡| 国产高清激情床上av| 免费人成在线观看视频色| 免费大片18禁| 国产精品一区二区三区四区免费观看 | 国产色爽女视频免费观看| 亚洲无线在线观看| 欧美不卡视频在线免费观看| 在现免费观看毛片| 色在线成人网| 一本精品99久久精品77| 亚洲国产欧美人成| 精品少妇黑人巨大在线播放 | 97人妻精品一区二区三区麻豆| 欧美另类亚洲清纯唯美|